GOP Lawmakers Scrutinize Low-Cost Drug Program

Law360, New York (March 6, 2012, 8:08 PM EST) -- Tensions between pharmaceutical firms and safety net hospitals are in the spotlight after four Republican lawmakers Monday outlined a wide-ranging inquiry into a discount drug program. 

In letters released Monday, three senators and a congressman raise questions about the so-called 340B program, which provides reduced-cost drugs to 16,500 health clinics and hospitals that serve low-income patients. Under the program, manufacturers must provide discounts — often in the range of 20 percent to 50 percent — in order to have their drugs covered by Medicaid.

The lawmakers...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.